The present study was conducted to obtain detailed information on the morphological changes in the human kidney as related to cisplatin therapy. The kidneys of ten autopsy cases showing impaired renal function following cisplatin therapy with hydration were examined histologically. Sporadic lesions of degeneration, necrosis, and regenerative changes were observed in the pars convoluta and pars recta of the proximal tubule, distal tubule, and collecting duct. Enlarged and pleomorphic nuclei in regenerated epithelial cells and hyperplasia of the collecting duct lining cells were considered to be specific histological findings in renal injury related to cisplatin therapy. Electron microscopic examination of a case receiving a large dose of cisplatin without signs of renal insufficiency showed an increased number of cytosomes containing electron dense granules in all tubular portions and conspicuous nuclear indentation in the thin limb of the loop of Henle and collecting duct. The platinum concentration in autopsy organs and biopsy cases was analyzed, but no correlation could be found between the concentration level of platinum in the kidney and impairment of renal function.
INTRODUC~ION
made on the kidneys of autopsy cases with slight to Cisplatin (cis-diamminedichloroplatinum; CDDP) is a coordinate metal complex with antineoplastic properties.
early clinical study with CDDP, nephrotoxicity was the major dose limiting toxicity. electron microscopically, that CDDP-induced cell injury and necrosis in the rat kidney were localized in the third segment of the proximal tubule (3, 4, severe renal functional impairment after CDDP treatment and vigorous hydration. A renal biopsy specimen obtained from a case receiving CDDP was also examined electron microscopically. The distribiopsy cases was analyzed, and the relationship between the histological changes in the kidney and the distribution of platinum in the organs is discussed.
Experimental studies have confirmed, both light and bution of Platinum in the organs ofthe autopsy and 11). On the other hand, pathological studies on the nephrotoxicity of CDDP in man are relatively few in number; the main injured sites reported are the distal tubule and collecting duct or the proximal and distal tubules (8, 11, 13, 23, 25, 28) . Although severe nephrotoxicity can now be prevented by employing aggressive hydration (1 2), renal functional impairment after CDDP is still being encountered. Furthermore, the exact mechanism by which nephrotoxicity is produced has not been established.
In the present study, histological observations were METHODS Histologic Exai,tinatio,i of Autopsy Cases. Ten patients who had received CDDP therapy with hydration or mannitol diuresis, followed by slight to severe renal functional impairment, were studied. The patients died within 60 days after the last dose of CDDP. The causes of death were not renal failure but respiratory or circulatory disturbance based on tumor metastases. The dosing schedules of CDDP, the hydration scheme, and survival days after the last dose of CDDP are listed in Table I Electron-probe X-ray analysis was camed out on unstained but osmicated ultra-thin sections by using a JEOL JEM-1200EX/ASIB/EDS (Tracer Northem). This instrument is equipped with an energy dispersive spectrometer.
Distribittion of Platittttrii in Tissues.
Eight autopsy cases who had received CDDP therapy were selected randomly and the tissue samples of organs cited in Table I11 were collected for platinum analysis. Analysis was made by an atomic absorption spectrometer using the flameless grafite atomizer (Nippon Kayaku Co.).
RESULTS

Dose and Clinical Findings.
Eight Japanese men and two women ranging in age from 18 to 76 years were included in this study. Each person was in the late stages ofcancer including four cases oftesticular carcinoma, 2 of lung cancer, one ovarian carcinoma, one prostate carcinoma, one pharyngeal carcinoma, and one esophageal carcinoma. Patients received at least one course of CDDP therapy. Two kinds of dose schedules were contained, one was a daily lowdose for five treatments and another was low-dose intermittent (5). The total doses of CDDP ranged from 77 mg/m2 to 240 mg/m2 and five cases received a combination chemotherapy of CDDP with other cytostatic drugs (Table I ). All cases received more than 2,000 ml of hydration, except for one case (Case No. 5 ) who did not receive pretreatment hydration. Mannitol diuresis was given in six cases.
Elevated BUN and serum creatinine levels were observed in four cases after the first course of CDDP treatment and in three cases after the second course. BUN levels began to increase from day 2 to day 7 after the last dose of CDDP; a gradual increase was noted in 5 cases. There was no significant elevation of BUN and serum creatinine levels in three pa- mentioned earlier, BUN and serum creatinine levels began to increase on day 3 after the last dose of CDDP and continued to elevate gradually with BUN and serum creatinine reaching a level of 104 mg/dl and 3.6 mlldl, respectively ( Fig. 1 ). Case Nos. 7 and 9 received gentamicin-cephazolin or gentamicin therapy following CDDP therapy. A mild transient elevation of BUN and serum creatinine was noted after CDDP therapy, and therapy with antibiotics was complicated by severe progressive acute renal failure, which persisted until death.
We were unable to demonstrate a correlation between the total dose of CDDP received and the level of BUN or serum creatinine. Furthermore, no difference in BUN levels was noted between patients on the daily low-dose treatment schedule and those on the low-dose intermittent schedule.
Histopathological Findings of Kidrieys Obtaiued by Autopsy. Since the kidneys examined in this study were obtained from cases with survival from 3 to 60 days after the last dose of CDDP, histopathological alterations were of various grades and in diverse stages. However, the following findings were in common in the majority of cases. Diffuse dilation of the proximal and distal tubules with intraluminal granular or hyaline casts was noted in 7 out of 10 cases. Swelling, hydropic or vacuolar degeneration, necrosis, and desquamation of the epithelial cells of the Droximal tubule were also noted. These lesions were not diffuse but were patchy in the pars convoluta and pars recta ( Figs. 2, 3 ). The tubules lined by regenerated epithelial cells were sporadically distributed, and these cells contained large, pleomorphic, and hyperchromatic nuclei. Regenerated epithelial cells with nuclear alteration were tients, but their creatinine clearance level dropped to less than 50 mumin after CDDP therapy (Table  11 ).
In Case No. 5 , who received less hydration as frequently present in the tubule containing hyaline casts ( Fig. 4 ). There was an eosinophilic degeneration and/or necrosis of the neck of the tubule (the transitional portion from Bowman's capsule to the proximal tubule) in four out of 10 cases ( Fig. 5 ).
Vacuolar degeneration, sloughing, and regeneration with nuclear pleomorphism were also noted sporadically in the epithelium of the distal tubule. The degree of seventy of these changes was less than those in the proximal tubule ( Fig. 6) .
Pyknosis and shrunken nuclei were obvious in the epithelial cells of the collecting ducts in the cortex and the medulla, with some ducts showing swelling and desquamation. In cases with moderate or severe renal functional impairment who survived for more than 20 days, there were polypoid epithelial hyperplastic lesions projecting into the lumen of the collecting ducts in the cortex and the medulla. The luminal surface of these tubules showed PNA binding ( Fig. 7) . Necrotic debris were frequently observed in the lumen of the thick limb of the loop of Henle. In those cases with severe tubular alteration, the interstitiurn was moderately edematous.
The appearance of regenerated epithelium and nuclear pleomorphism was prominent in those cases surviving for more than 10 days. On the other hand, the kidney of one case (No. l), surviving for only three days after the last dose ofCDDP with mannitol diuresis, showed diffuse vacuolar degeneration in the proximal tubule as seen in osmotic nephrosis. This kidney also showed focal necrosis in the neck, the pars convoluta, and recta of the proximal tubule and the distal tubule.
Kidneys obtained from patients given antibiotics following CDDP therapy showed diffuse vacuolar degeneration, necrosis, and desquamation of epithelial cells of the proximal tubules in addition to alterations related to CDDP therapy,
Histopathological arid Electron Microscopic
Findings in the Renal Biopsy Speciineri. The kidney was obtained from a patient receiving a high CDDP dose as 576 mg/m2 in total dose without abnormality of renal function (BUN: 16 mg/dl, serum creatinine: 1.1 mg/dl). Nephrectomy was performed on day 13 after the last dose of CDDP.
In general, there were no remarkable histopathologic changes. Eosinophilic degeneration with pyknosis, however, was noted in a small number of epithelial cells in the neck and the proximal tubule. Distal tubules were dilated' and contained proteinaceous material; a small number of hydropic epithelial cells with pyknosis were seen sporadically. Minute polypoid epithelial hyperplasia and brown pigment deposition were observed in the collecting duct.
Electron microscopic findings revealed a small number of epithelial cells with apical blebbing and focal loss of the brush border was noted in the pars convoluta and pars recta. These cells contained cytosomes with electron dense contents in the apical blebbing portion and condensed mitochondria (Fig.  8a) . The necrotic tubular cells sloughing into the lumen were found to include mitochondria, cytosomes, and disrupted membranes. The non-impaired epithelial cells of the proximal' tubule contained numerous cytosomes that had a dense Vol. 14 homogenous background matrix (Fig. 8b) . These cytosomes contained many very dense bodies.
In the distal tubule, electron dense cytosomes with lipid droplets, similar to lipofuscin, and a slight dilatation of endoplasmic reticulum were frequently observed. Large cytosomes containing electron dense homogenous contents with only a suggestive limiting membrane were seldom observed ( Fig. 9) . Large cytosomes, similar to lipofuscin, were frequently seen in the thin limb of the loop of Henle and in the collecting duct in the medulla. They contained dense and granular substances. The nuclei of lining epithelial cells were remarkably indented and contained abundant heterochromatin (Fig. 10) .
No platinum was detected with electron-probe X-ray analysis in the cytosomes and cell cytoplasma of epithelial cells of the proximal tubule and the thin limb of the loop of Henle.
Platinum Analyses in Tissues. Table 111 lists the individual and average platinum concentration levels for one group of patients surviving for less than two months after the last dose of CDDP. Table I11 also lists these values for another group of patients surviving for more than two months. In the first group, the highest level was found inthe liver, followed by the kidney and gastro-intestinal tract. The concentration ofplatinum in each organ in the second group was generally lower than that of the first. In the second group the highest levels were found in the liver, followed by the GI tract, and then the kidney and heart. Over time, the concentration of platinum decreased faster from the liver and lung, followed by the kidney. There was a positive correlation between the concentration level of platinum in the liver and that found in the kidney (Fig. 1 1) . A correlation between the total dose of CDDP 
DISCUSSION
The nephrotoxicity of the platinum coordinate complex (cisplatin) has been established in animals. It has also been demonstrated, both histologically and electron microscopically, that CDDP induced acute tubular necrosis of the S3 segment of the proximal tubule, located in the outer medulla in rats. There are, however, only a few reports concerned with histological studies on the renal changes related to CDDP therapy in man. Gonzalez-Vitale et a1 found that the distal tubules and collecting ducts were affected primarily, and to a greater degree, more than the proximal convoluted tubules (1 1). On the other hand, Dentino et a1 noted segmental cellular necrosis and hydropic degeneration in the proximal and distal tubules (8) . Both authors cited nuclear pleomorphism, atypism, and hyperchromasia.
We examined histologically the kidneys obtained from cases surviving for 3 to 60 days after the last dose of CDDP. Segmental degeneration, necrosis, and desquamation of the epithelial cells were noted in the pars convoluta and pars recta of the proximal tubule, distal tubule, and collecting duct. Nephro-toxic substances are known to affect a given segment of tubules (29) , but the target portion of the tubule affected by CDDP.in man is considered to be larger than with other nephrotoxic substances. The epithelial alterations of tubules, as related to CDDP therapy, were never diffuse but were segmental or focal.
CDDP produces different histopathological features in the human kidney than in the rat kidney. Enlarged and hyperchromatic nuclei were noted in the regenerated epithelium in the proximal and distal tubules. Nuclear pleomorphism was frequently seen in the epithelium of the collecting duct, and nuclear invaginations were noted electron microscopically. In three cases surviving for 26, 27, and 45 days, respectively, there were small hyperplastic lesions of epithelial cells of the collecting duct, and similar lesions were also noted in the biopsy specimens. It was suspected that the lesions in the collecting ducts might be a specific finding related to CDDP therapy in man.
Although Gonzalez-Vitale et a1 noted that the distal tubule and collecting duct were affected primarily by CDDP in man (1 l), the shortest survival case in our study, three days after the last dose, showed focal necrosis of epithelial cells of the neck, pars convoluta and pars recta of the proximal tubule and distal tubule, with focaI swelling of epitheIial cells of the collecting duct. Primary lesions affected by CDDP in man were considered to be situated not only in the distal tubules and collecting ducts but also in the neck and proximal tubule.
Creatinine clearance is known to be one indicator of renal failure induced by CDDP (9, 27) . No remarkable histological changes were found in the kidneys of cases that didn't show elevated BUN and serum creatinine levels but did show decreased creatinine clearance. Enlarged nuclei, however, were seen occasionally in the regenerated epithelial cells, and it was suspected that the tubular epithelium had been injured to some degree.
It has been reported that gentamicin-cephalothin therapy after CDDP could lead to severe nephrotoxicity (12, 26) . In our cases these antibiotics were used following CDDP therapy in two cases. These cases showed histological changes in the proximal tubules resembling aminoglycoside nephropathy.
Electron microscopic findings from kidneys of humans receiving CDDP and showing renal failure were reported by Dentino et a1 and Mizunuma et a1 (8, 23) . They noted increased numbers of cytoplasmic vacuoles, endoplasmic reticular dilatation, and mitochondria1 swelling. In our study, the main changes consisted of increased numbers of cytosomes containing electron dense contents in the epithelial cells of proximal and distal tubules, the thin TOXICOLOGIC PATHOLOGY 256 limb of the loop of Henle, and collecting ducts; a promineni nuclear indentation appeared in the latter two structures.
Although the highest concentration level of platinum was detected in the kidney of the biopsy case, electron-probe X-ray analysis did not show platinum in the ultra-thin sections ofthis specimen. Some of the reasons for these results could be that an adequate amount of platinum did not accumulate in the target to be detected, that osmication of the specimen hindered the detection of platinum, or it may have dissolved away during fixation or dehydration. Two papers concerning X-ray microanalysis of platinum in the cells have been reported (2, 10) . In an experimental study of CDDP in the rat, it was reported that lysosomes containing dense granulation contained platinum (2), but no clear platinum peak was demonstrated in their study. Ghadially et a1 showed the presence of platinum in lysosomes of a lymphoblastic cell line (RPMI 64 10) cultured with platinumuracil blue but not in the cells cultured with CDDP (10).
The concentration of platinum in tissues of patients receiving CDDP was reported by Hill in 1975 (14) . We examined the concentration of platinum in organs of autopsy cases regardless of renal functional impairment. The highest level of platinum was noted in the liver, followed by the kidney and GI tract. Several authors reported the distribution of platinum in organs following administration of CDDP in dogs (20) (21) (22) . Data up to day 12 after CDDP administration showed that a higher level was noted in the kidney than that in the liver, but data after 12 weeks showed a higher level in the liver than that in the kidney. A report by Hill indicated that the highest level of platinum was found in the kidney of a case surviving for 2 days after CDDP therapy, but the level in the liver was higher than in the kidney of a case surviving for 25 days
The pharrnacokinetics of CDDP in man has not been fully clarified. If there were no differences in the pharmacokinetics of CDDP in humans and dogs, one would suspect that the concentration of platinum would be higher in the kidney during a few weeks following CDDP administration. However, the concentration in the kidney might decrease and platinum might still remain in the liver after several weeks. Since our specimens were obtained from patients surviving for 35 days to eight months, the concentrations of platinum in the kidney were considered to have decreased. Himmelstein et a1 reported that three species, namely total platinum, non-protein bound platinum, and non-protein bound unchanged drug, were monitored in human plasma after intravenous injection of CDDP. The non-pro-
(14).
tein bound species level declined in a monophasic manner and exhibited a half life between 0.3 to 0. 5  hours (1, 15) . On the other hand, it is said that only free circulating platinum species seem to have a cytotoxic activity in humans (1 6). Daley-Yates et a1 showed that the non-protein bound ultra-filtrable species had a nephrotoxic activity in the rat (7) . These results indicate that nephrotoxic metabolites ofCDDP disappear from serum within several hours, and platinum remaining in the body for a long period is probably the protein-bound species with low nephrotoxic activity. It is conceivable from this hypothesis that there is no correlation between concentration levels in the kidney and renal failure in our cases.
Although Dentino et a1 suspected that platinum remaining for a long time in tissues might cause ongoing renal damage, platinum deposited in the kidney as long as eight months following administration of CDDP did not induce prominent changes in renal tissue in our cases.
Following infusion of CDDP, up to 45% of platinum is excreted in the urine within the first five days (6). Jacobs et a1 reported that free platinum clearance was greater than the glomerular filtration, and CDDP or its metabolites were secreted by the renal tubules and inhibited by probenecid (1 8, 19 ). Furthermore, studies in rats showed localized damage to the S3 segment of the proximal tubule, and renal injury induced by CDDP was significantly reduced by probenecid treatment (24). Jacobs et al linked these facts together and speculated that accumulation of platinum in the pars recta might be the exact mechanism for the nephrotoxicity ofCDDP (1 9). However, since the injured sites of the kidney relating to CDDP therapy in humans were not only the pars recta of the proximal tubule, it is difficult to explain the mechanism of nephrotoxicity of CDDP in humans by only the secretory process of CDDP.
